Salicylanilide ester prodrugs as potential antimicrobial agents--a review
Language English Country United Arab Emirates Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
22074422
DOI
10.2174/138161211798194521
PII: BSP/CPD/E-Pub/000729
Knihovny.cz E-resources
- MeSH
- Anti-Bacterial Agents * adverse effects chemistry pharmacology MeSH
- Antifungal Agents * adverse effects chemistry pharmacology MeSH
- Esters MeSH
- Humans MeSH
- Molecular Structure MeSH
- Prodrugs * adverse effects chemistry pharmacology MeSH
- Drug Design * MeSH
- Salicylanilides * adverse effects chemistry pharmacology MeSH
- Structure-Activity Relationship MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Anti-Bacterial Agents * MeSH
- Antifungal Agents * MeSH
- Esters MeSH
- Prodrugs * MeSH
- Salicylanilides * MeSH
Salicylanilides have been a subject of interest in medicinal chemistry as a group with a wide range of biological activities. The antibacterial (including antimycobacterial) and antifungal activities have come to be viewed as very significant. The synthesis of new prodrugs to counter a number of problematic properties of salicylanilides is a current trend. This article brings together the known basic facts about these prodrugs, particularly about the different mechanisms of the antimicrobial action of salicylanilides, including salicylanilide toxicity and undesired effects. The largest part of this group consists of antimicrobial salicylanilide esters with different organic acids, e.g. acetates, carbamates, esters with N-protected amino acids, and mutual antibacterial compounds with known antibacterial agents (β-lactames and linezolid), with the activity and structure-activity relationships of these compounds being of particular interest. This review summarizes the activity of salicylanilides as potential virulence inhibitors attributable to a blockade of the type III secretion pathway. Many salicylanilide ester derivatives have been demonstrated an effective and promising treatment against pathogenic fungi and bacteria (especially against Gram-positive, tuberculous and atypical mycobacterial strains), including strains such as methicillin-resistant Staphylococcus aureus and isoniazid-resistant mycobacteria which are resistant to one or more clinically used drugs.
References provided by Crossref.org
Study of Biological Activities and ADMET-Related Properties of Salicylanilide-Based Peptidomimetics
2-Hydroxy-N-phenylbenzamides and Their Esters Inhibit Acetylcholinesterase and Butyrylcholinesterase
Design, Synthesis and Evaluation of N-pyrazinylbenzamides as Potential Antimycobacterial Agents
N-Alkoxyphenylhydroxynaphthalenecarboxamides and Their Antimycobacterial Activity
Novel Cholinesterase Inhibitors Based on O-Aromatic N,N-Disubstituted Carbamates and Thiocarbamates
Synthesis and Biological Evaluation of N-Alkoxyphenyl-3-hydroxynaphthalene-2-carboxanilides
Antibacterial and herbicidal activity of ring-substituted 3-hydroxynaphthalene-2-carboxanilides
Antibacterial activity of salicylanilide 4-(trifluoromethyl)-benzoates
Antifungal Activity of Salicylanilides and Their Esters with 4-(Trifluoromethyl)benzoic Acid
Antimycobacterial activity of salicylanilide benzenesulfonates